Lindsay B. Avery

Publications by Year

Research Areas

Monoclonal and Polyclonal Antibodies Research, Protein purification and stability, Innovative Microfluidic and Catalytic Techniques Innovation, HIV Research and Treatment, Glycosylation and Glycoproteins Research

Most-Cited Works

• → Dendritic Spine Injury Induced by the 8-Hydroxy Metabolite of Efavirenz(2012)132 cited
• → Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodies(2016)109 cited
• → Linear pharmacokinetic parameters for monoclonal antibodies are similar within a species and across different pharmacological targets: A comparison between human, cynomolgus monkey and hFcRn Tg32 transgenic mouse using a population-modeling approach(2018)103 cited
• → A Selective Phenelzine Analogue Inhibitor of Histone Demethylase LSD1(2014)100 cited
• → Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics(2017)97 cited
• → Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics(2017)75 cited
• → Pharmacological activation of myosin II paralogs to correct cell mechanics defects(2015)71 cited
• → Valproic Acid Is a Novel Activator of AMP-Activated Protein Kinase and Decreases Liver Mass, Hepatic Fat Accumulation, and Serum Glucose in Obese Mice(2013)57 cited
• → A Physiologically‐Based Pharmacokinetic Model for the Prediction of Monoclonal Antibody Pharmacokinetics FromIn VitroData(2019)44 cited
• → Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques(2013)42 cited